An energy tool for a surgical robotic system, the energy tool comprising: a jaw coupled to a base, the jaw having a first anvil that moves relative to a second anvil between an open position and a closed position; and at least one of a force sensor, a temperature sensor and an acoustic sensor coupled to the jaw.

The present disclosure is directed to systems and methods for determining an end of life state for an electromechanical surgical system. The system includes an end effector configured to perform at least one function and a shaft assembly being arranged for selectively interconnecting the end effector and a hand-held surgical instrument. The hand-held surgical instrument includes an instrument housing defining a connecting portion for selectively connecting with the shaft assembly. The hand-held surgical instrument also includes a motor assembly, a sensor array configured to obtain an operational parameter of the hand-held surgical instrument, and a controller configured to control operation of the hand-held surgical instrument based on the operational parameter obtained by the sensor array.

A method of therapy for a tumor or other pathology by administering thermotherapy or a combination of thermotherapy and immunotherapy optionally combined with gene delivery. The combination therapy beneficially treats the tumor and prevents tumor recurrence, either locally or at a different site, by boosting the patient's immune response both at the time of original therapy and/or for later therapy. The therapy may further include the administration of a vaccine.

A computer-assisted medical device is configured and used to endoluminally navigate to a location in the gastrointestinal system and there treat certain body lumen wall areas while avoiding other body lumen wall areas. Embodiments ablate the inner mucosal layer and sub-mucosal nerve plexus of the stomach, duodenum and jejunum to effect treatment of insulin resistance and metabolic disorders, such as Type II diabetes (T2D), polycystic ovarian syndrome (PCOS), non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), congestive heart failure (CHF) and obstructive sleep apnea (OSA). Various sensors are used to assist a clinical operator to navigate from the mouth through the pyloric sphincter and into and through the duodenum and/or jejunum. Various sensors are used to map and identify portions of the duodenum and/or jejunum. Various lumen wall ablation devices and methods are described. Various post-treatment assessments are described.

Various aspects of a generator, ultrasonic device, and method for estimating a state of an end effector of an ultrasonic device are disclosed. The ultrasonic device includes an electromechanical ultrasonic system defined by a predetermined resonant frequency, including an ultrasonic transducer coupled to an ultrasonic blade. A control circuit measures a complex impedance of an ultrasonic transducer, wherein the complex impedance is defined as $Z_g\left(t\right)=\frac{V_g\left(t\right)}{I_g\left(t\right)}.$
The control circuit receives a complex impedance measurement data point and compares the complex impedance measurement data point to a data point in a reference complex impedance characteristic pattern. The control circuit then classifies the complex impedance measurement data point based on a result of the comparison analysis and assigns a state or condition of the end effector based on the result of the comparison analysis.

A surgical instrument is disclosed. The surgical instrument comprises an end effector comprising an ultrasonic blade and a clamp arm. The clamp arm is movable relative to the ultrasonic blade to transition the end effector between an open configuration and a closed configuration to clamp tissue between the ultrasonic blade and the clamp arm. The surgical instrument further comprises an ultrasonic transducer configured to generate an ultrasonic energy output and a waveguide configured to transmit the ultrasonic energy output to the ultrasonic blade. The surgical instrument further comprises a control circuit, configured to detect an immersion of the end effector in a liquid and compensate for heat flux lost due to the immersion of the end effector in the liquid.

A method of assessing inter-device communication pairing in a surgical setting, may include transmitting, by a first intelligent medical device, wireless communication data within the surgical setting, receiving, by a second intelligent medical device, the wireless communication data from the first intelligent medical device, determining, by the second intelligent medical device, communication pairing data indicative of an inter-device communication pairing of the second intelligent medical device with the first intelligent medical device, transmitting, by the second intelligent medical device, the communication pairing data to a modular control tower, and displaying, by the modular control tower on a display device, an augmented reality display comprising one or more virtual objects indicative of the inter-device communication pairing. An interactive surgical system may include multiple intelligent medical devices and displays which can form communication pairs in this manner.

A computer-assisted medical device is configured and used to endoluminally navigate to a location in the gastrointestinal system and there treat certain body lumen wall areas while avoiding other body lumen wall areas. Embodiments ablate the inner mucosal layer and sub-mucosal nerve plexus of the stomach, duodenum and jejunum to effect treatment of insulin resistance and metabolic disorders, such as Type II diabetes (T2D), polycystic ovarian syndrome (PCOS), non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), congestive heart failure (CHF) and obstructive sleep apnea (OSA). Various sensors are used to assist a clinical operator to navigate from the mouth through the pyloric sphincter and into and through the duodenum and/or jejunum. Various sensors are used to map and identify portions of the duodenum and/or jejunum. Various lumen wall ablation devices and methods are described. Various post-treatment assessments are described.

A powered surgical stapling assembly comprising a motor, an end effector, a sensor, a display, and a control circuit is disclosed. The end effector comprises a first jaw and a second jaw movable relative to the first jaw. The end effector is configured to clamp tissue between the first jaw and the second jaw. The sensor is configured to measure a parameter of the tissue clamped within the end effector. The control circuit is configured to monitor the parameter sensed by the sensor and identify when the monitored parameter stabilizes within a stabilization range. The monitored parameter is considered stable when a rate at which the monitored parameter changes falls below a predetermine threshold rate of change. The control circuit is further configured to display to a user when the parameter stabilizes.

A method of controlling the temperature of an ultrasonic blade includes applying a power level to an ultrasonic transducer to achieve a desired temperature at an ultrasonic blade coupled to the transducer via an ultrasonic waveguide, inferring a temperature of the blade based on a voltage V.sub.g(t) signal and a current I.sub.g(t) signal applied to the transducer, comparing the inferred temperature of the blade to a predetermined temperature; and adjusting the power level to the transducer based on the comparison. In some aspects, the method includes measuring a phase angle φ between the voltage V.sub.g(t) and the current I.sub.g(t) and inferring the temperature of the blade from the phase angle φ. In some aspects, the method includes measuring an impedance Z.sub.g(t) equal to a ratio of the voltage V.sub.g(t) to the current I.sub.g(t) and inferring the temperature of the blade from the impedance Z.sub.g(t).